Garden State Investment Advisory Services’s Novo Nordisk NVO Stock Holding History

Garden State Investment Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$313K	Buy	+6,526	New	+$280K	0.06%	239
2025 Q3	–	Sell	-7,059	Closed	-$487K	–	337
2025 Q2	$487K	Buy	7,059 +3,167	+81%	+$215K	0.12%	151
2025 Q1	$274K	Buy	3,892 +273	+8%	+$22.5K	0.09%	193
2024 Q4	$312K	Buy	3,619 +1,476	+69%	+$160K	0.09%	176
2024 Q3	$255K	Sell	2,143 -130	-6%	-$17.3K	0.08%	189
2024 Q2	$325K	Sell	2,273 -179	-7%	-$23.7K	0.11%	158
2024 Q1	$314K	Buy	2,452 +383	+19%	+$45.6K	0.11%	166
2023 Q4	$214K	Buy	+2,069	New	+$205K	0.09%	190

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Garden State Investment Advisory Services's NVO Position: Q2 2026 in Review

Garden State Investment Advisory Services opened a new position in Novo Nordisk (NVO) in Q2 2026: 6,526 shares worth $313K. The stake represents 0.06% of the portfolio and ranks #239 among its holdings. This is a return to the name: Garden State Investment Advisory Services previously reported a position in NVO as recently as Q2 2025.

Garden State Investment Advisory Services first reported a position in NVO in Q4 2023 and has held it in 8 quarters since. The position peaked at $487K in Q2 2025. 1,358 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Garden State Investment Advisory Services held 6,526 shares of Novo Nordisk worth $313K as of Q2 2026.
Novo Nordisk was a new Garden State Investment Advisory Services position in Q2 2026.
Novo Nordisk made up 0.06% of Garden State Investment Advisory Services's portfolio in Q2 2026, its #239 holding.
Garden State Investment Advisory Services first reported a position in Novo Nordisk in Q4 2023 and has held it in 8 quarters since.
Garden State Investment Advisory Services's Novo Nordisk position peaked at $487K in Q2 2025.
1,358 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Garden State Investment Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.